Ovarian Hormone Therapy OHT

Ovarian Hormone Therapy means the combination of an estrogen and progesterone (or a synthetic progestin) for the purpose of treating a health issue in menopausal women. Since we now know that estrogen-based treatment of menopausal without symptoms causes harms (blood clots, strokes, gall bladder surgery, incontinence) and does not prolong life or prevent heart disease (based on the Women’s Health Initiative Randomized controlled trials), the concept of menopausal hormone “replacement” is now wrong. OHT is meant to replace this wrong “HRT” concept and to remind us that women have two reproductive hormones—estrogen and progesterone.For years, CeMCOR has said that there are only three good reasons to use OHT: 1) Menopause too early (before age 40); 2) Severe hot flushes/flashes and night sweats; and 3) Prevention of bone loss in women with hot flushes needing therapy who are early in menopause and have osteoporosis by bone density or fragility fractures. Now, with the discovery that oral micronized progesterone (PrometriumÒ or compounded progesterone in olive oil) is effective treatment for hot flushes, that removes #2 from the list.Ovarian hormone therapy should not be continued for more than five years (breast cancer risk on estrogen alone or estrogen-progestin significantly increases after that time). The ideal estrogen for OHT is estradiol used as a gel, patch or cream since this form of estrogen doesn’t increase the risk for blood clots. Doses vary by type but should be no more than 1 pump of the estradiol gel or the equivalent of 0.5 micrograms/d by patch or cream. Taking three to five days off estradiol each month is more physiological and allows the breasts a break from estrogen’s stimulation. The ideal partner hormone with estradiol (for all menopausal women for whom OHT is indicated, whether or not they have had a hysterectomy) is progesterone taken at bedtime in a dose of 200-300 mg every day or 300 mg for at least 14 days a month (which will probably cause vaginal flow). The progesterone dose of 300 mg at bedtime is not a high dose but one that is required to keep the blood level within the normal luteal phase range for the full 24 hour day. Progesterone improves sleep (and thus may decrease risks for obesity and depression). Progesterone also makes possible the effective tapering and discontinuation of estrogen treatment for hot flushes in those wishing to, or for whom there are medical reasons, to stop.

  • Progesterone is NOT a Progestogen/Progestin— It’s Estrogen’s Unique Biological Partner

    This article was originally published in our e-newsletter. by Dr. Jerilynn C. Prior, Scientific Director, Centre for Menstrual Cycle and Ovulation Research Current lay and medical women’s health literature considers progesterone, the human hormone made by women’s ovary in the same category as its synthetic, “knock-offs”. “Progestogens. . .include both endogenous progesterone and synthetic progestogens…

  • Hormone therapy and Ovarian Cancer risk

    What’s your opinion on the paper that came out in Lancet about hormone therapy and ovarian cancer? What does this really mean for women?

  • Progesterone for Hot Flashes: NAMS eConsult

    Hot flushes/flashes and night sweats have conventionally been considered to be caused by estrogen deficiency and thus their major treatment is estrogen. Dr Jerilynn Prior was invited in November 2013 by the editors of the online blog (eConsult) for the North American Menopause Society to write about progesterone treatment of hot flashes. Here is the article: “Progesterone…

  • Beyond “Estrogen Deficiency”—news from Women’s Health Initiative

    The USA’s National Institutes of Health just announced that the Estrogen arm of the Women’s Health Initiative was stopped early (1). Estrogen treatment in women who had undergone hysterectomy was associated with neither benefit nor harm for heart disease and caused a 40% increase in stroke (1). No one can ever again say that estrogen…

  • The Death of Hormone Replacement Therapy — Why and how to use Ovarian Hormone Therapy

    A response to the cancelled Women’s Health Initiative study and call for a healthier look at menopause Dr. Jerilynn C. Prior, Scientific Director of the Centre for Menstrual Cycle and Ovulation Research, has never advocated the use of hormones as an ongoing “replacement” for menopause. She does not feel that menopause is a medical condition…